Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

New standard listing: Ajax Resources seeks resources reversal

Marshalls agrees Marley purchase

New Aquis admission: ProBiotix Health spin-off

First Tin Primary Bid offer closes on Thursday

Medica elective surgery boost

Why companies left AIM in March 2022

Aquis Exchange quadruples earnings

S&U dividend surpasses pre-Covid level

Scandinavian reversal for Media Tech SPAC

AIM reversal: Celadon’s growing plans for cannabis

New standard listing: Beacon Rise’s unheralded float

Recycling Technologies returns

New standard listing: RC365 payments technology roll out

Tasty recovery

Tip update: Disappointing Destiny still has potential

Standard reversal: Ondo Insurtech leak detection

Tip update: More good German news for Hargreaves

New AIM admission: CleanTech Lithium set for updated resource

OptiBiotix spinning off ProBiotix Health on Aquis

New standard listing: New Energy One seeks transition deal

Standard reversal: CYBA prospects in the US

Gfinity raising more cash

Franchise Brands upgrade

Aquis planning Aquis Stock Exchange quote

Aquis Stock Exchange February 2022 trading

Why companies left AIM in January and February

Focusrite stays in tune with audio market

New Aquis admission: Majestic recycling plans

New standard listing: Website problems at Codex Acquisitions

Various Eateries returns to growth

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020